Goldman Sachs Group Inc Harmony Biosciences Holdings, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 720,681 shares of HRMY stock, worth $23.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
720,681
Previous 344,766
109.03%
Holding current value
$23.4 Million
Previous $11.4 Million
99.03%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding HRMY
# of Institutions
289Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$215 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$190 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$166 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$53 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$51.4 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.92B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...